Page last updated: 2024-10-19

melatonin and Brain Neoplasms

melatonin has been researched along with Brain Neoplasms in 71 studies

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research Excerpts

ExcerptRelevanceReference
"Melatonin exerts oncostatic effects on breast cancer via immunomodulation and antioxidation."8.12Effects of Melatonin and Doxorubicin on Primary Tumor And Metastasis in Breast Cancer Model. ( Aytac, G; Dilmac, S; Farooqi, AA; Sindel, M; Tanriover, G, 2022)
"In the present research, we report that melatonin or its agonist, agomelatine, induced autophagy in A172 and U87-MG glioblastoma cells for a concentration-and time-dependent way, which was significantly attenuated by treatment with luzindole, a melatonin receptor antagonist."7.91Inhibition of autophagy triggers melatonin-induced apoptosis in glioblastoma cells. ( Qi, ZX; Wei, ZX; Zhou, N, 2019)
"Melatonin, an indolamine mostly synthesized in the pineal gland, exerts the anti-cancer effect by various mechanisms in glioma cells."7.85Melatonin inhibits proliferation and invasion via repression of miRNA-155 in glioma cells. ( Chen, Y; Gu, J; Ji, C; Lei, Z; Li, X; Liu, Y; Lu, Z; Wang, L; Zhang, HT, 2017)
"The possibility of natural cancer therapy has been recently suggested by advances in the knowledge of tumor immunobiology."6.69Biotherapy with the pineal immunomodulating hormone melatonin versus melatonin plus aloe vera in untreatable advanced solid neoplasms. ( Giani, L; Lissoni, P; Rovelli, F; Trabattoni, P; Zerbini, S, 1998)
"A pineal cyst is a benign affection of the human pineal gland on the borderline between pathology and normality."5.46Melatonin and cortisol secretion profile in patients with pineal cyst before and after pineal cyst resection. ( Beneš, V; Bradáč, O; Májovský, M; Netuka, D; Pospíšilová, L; Řezáčová, L; Sumová, A, 2017)
"Pretreatment with melatonin effectively promoted Nrf2 activation and reversed the METH-induced NF-κB response."5.42Melatonin Protects Methamphetamine-Induced Neuroinflammation Through NF-κB and Nrf2 Pathways in Glioma Cell Line. ( Govitrapong, P; Jumnongprakhon, P; Pinkaew, D; Tocharus, C; Tocharus, J, 2015)
"Melatonin is an indolamine mostly produced in the pineal gland, soluble in water, and highly lipophilic, which allows it to readily cross the blood-brain barrier."5.33Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin. ( Antolín, I; Carrera-Gonzalez, P; García-Santos, G; Herrera, F; Martín, V; Rodriguez, C; Rodriguez-Blanco, J, 2006)
"Melatonin secretion was nearly absent in the patients with pineal germinoma regardless of treatment option, even in the patient who had been untreated."5.30Twenty-four hour rhythm of melatonin in patients with a history of pineal and/or hypothalamo-neurohypophyseal germinoma. ( Hashimoto, S; Honma, K; Ikeda, J; Murata, J; Sawamura, Y, 1998)
"Findings will provide timely information on the safety, efficacy, and optimal dosing of t-PA to treat moderate/severe COVID-19-induced ARDS, which can be rapidly adapted to a phase III trial (NCT04357730; FDA IND 149634)."4.21 ( Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y, 2022)
"Melatonin exerts oncostatic effects on breast cancer via immunomodulation and antioxidation."4.12Effects of Melatonin and Doxorubicin on Primary Tumor And Metastasis in Breast Cancer Model. ( Aytac, G; Dilmac, S; Farooqi, AA; Sindel, M; Tanriover, G, 2022)
"In the present research, we report that melatonin or its agonist, agomelatine, induced autophagy in A172 and U87-MG glioblastoma cells for a concentration-and time-dependent way, which was significantly attenuated by treatment with luzindole, a melatonin receptor antagonist."3.91Inhibition of autophagy triggers melatonin-induced apoptosis in glioblastoma cells. ( Qi, ZX; Wei, ZX; Zhou, N, 2019)
"Melatonin, an indolamine mostly synthesized in the pineal gland, exerts the anti-cancer effect by various mechanisms in glioma cells."3.85Melatonin inhibits proliferation and invasion via repression of miRNA-155 in glioma cells. ( Chen, Y; Gu, J; Ji, C; Lei, Z; Li, X; Liu, Y; Lu, Z; Wang, L; Zhang, HT, 2017)
"In 66 patients with some diseases of the nervous system (epilepsy, brain tumors, traumatic brain lesions, discorgenic lumbosacral radiculitis) melatonin content in liquor was determined by a fluorimetric method, especially modified for this purpose."3.65[Cerebrospinal fluid melatonin in diseases of the nervous system]. ( Kiselev, VN; Loboda, EB; Makarov, AIu, 1977)
"Confirmed lesions included pineocytoma WHO grade I (60."3.01Primary Gamma Knife Radiosurgery for pineal region tumors: A systematic review and pooled analysis of available literature with histological stratification. ( De Domenico, P; Gagliardi, F; Garbin, E; Mortini, P; Snider, S, 2023)
"Melatonin was continued until neurologic deterioration or death."2.73Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119). ( Berk, L; Berkey, B; Blask, D; Gallagher, M; Hrushesky, W; Kudrimoti, M; McGarry, RC; Mehta, M; Rich, T; Suh, J, 2007)
"The possibility of natural cancer therapy has been recently suggested by advances in the knowledge of tumor immunobiology."2.69Biotherapy with the pineal immunomodulating hormone melatonin versus melatonin plus aloe vera in untreatable advanced solid neoplasms. ( Giani, L; Lissoni, P; Rovelli, F; Trabattoni, P; Zerbini, S, 1998)
"Unresectable brain metastases remain an untreatable disease."2.67A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms. ( Ardizzoia, A; Barni, S; Conti, A; Lissoni, P; Maestroni, G; Tancini, G, 1994)
"Melatonin has been considered in biological processes and in signaling pathways involved in the development of glioma."2.66The effects of melatonin on signaling pathways and molecules involved in glioma. ( Asemi, Z; Neamati, F, 2020)
" Furthermore, the non-cytolytic and non-cytotoxic metronomic dosage of hydroxyurea and temozolomide had increased the DBM therapy outcome by strengthening anti-tumor capability."1.62A retrospective observational study on cases of anaplastic brain tumors treated with the Di Bella Method: A rationale and effectiveness. ( Borghetto, V; Costanzo, E; Di Bella, G, 2021)
"Low melatonin profiles were observed in 31% and 4% had a phase-shifted daytime peak, compared with 14% and 0%, respectively, in children with tumours located elsewhere."1.62Brain tumours in children and adolescents may affect the circadian rhythm and quality of life. ( Feldt-Rasmussen, U; Jennum, P; Klose, M; Main, KM; Mathiasen, R; Pickering, L; Sehested, A, 2021)
"Melatonin is an important regulator in human circadian rhythms and the sleep-wake cycle."1.48Melatonin secretion following brain midline irradiation is diminished, but not correlated with subjective sleep disturbances. ( Brabant, G; Clusmann, H; Gebauer, J; Kreitschmann-Andermahr, I; Piroth, M; Rosenkranz, E; Siegel, S; Thissen, A, 2018)
"A pineal cyst is a benign affection of the human pineal gland on the borderline between pathology and normality."1.46Melatonin and cortisol secretion profile in patients with pineal cyst before and after pineal cyst resection. ( Beneš, V; Bradáč, O; Májovský, M; Netuka, D; Pospíšilová, L; Řezáčová, L; Sumová, A, 2017)
"Gliomas, the most common primary brain tumors in adults, are classified into four malignancy grades according to morphological features."1.43Melatonergic system-based two-gene index is prognostic in human gliomas. ( Carvalho-Sousa, CE; Fernandes, PA; Kinker, GS; Marie, SK; Markus, RP; Muxel, SM; Oba-Shinjo, SM, 2016)
"Melatonin has been associated with various tumors, including brain tumor, and shown to inhibit growth of neuroblastoma cells and gliomas in animal models."1.43Pineal calcification is associated with pediatric primary brain tumor. ( Johns, J; Johns, NP; Kanpittaya, J; Kitkhuandee, A; Tuntapakul, S, 2016)
"Pretreatment with melatonin effectively promoted Nrf2 activation and reversed the METH-induced NF-κB response."1.42Melatonin Protects Methamphetamine-Induced Neuroinflammation Through NF-κB and Nrf2 Pathways in Glioma Cell Line. ( Govitrapong, P; Jumnongprakhon, P; Pinkaew, D; Tocharus, C; Tocharus, J, 2015)
"Melatonin not only plays an important role in regulating circadian rhythms, but is also involved in antioxidative defense and immunomodulation."1.39Serotoninergic and melatoninergic systems are expressed in mouse embryonic fibroblasts NIH3T3 cells. ( Liu, YJ; Meng, FT; Wu, L; Zhou, JN, 2013)
"Melatonin actions were analysed by viability cell assays, flow cytometry, quantitative PCR for mRNA expression, western blot for protein expression and quantitative and qualitative promoter methylation methods."1.39Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells. ( Alvarez-Vega, MA; Antolín, I; Fueyo, J; Gomez-Manzano, C; Herrera, F; Martín, V; Rodriguez, C; Sanchez-Sanchez, AM, 2013)
"Melatonin rhythm was dramatically reduced for undifferentiated or invasive tumors."1.35Contribution of the daily melatonin profile to diagnosis of tumors of the pineal region. ( Brun, J; Champier, J; Chazot, G; Claustrat, B; Fèvre-Montange, M; Jouvet, A; Leston, J; Mottolese, C; Sindou, M, 2009)
"Melatonin is an indolamine mostly produced in the pineal gland, soluble in water, and highly lipophilic, which allows it to readily cross the blood-brain barrier."1.33Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin. ( Antolín, I; Carrera-Gonzalez, P; García-Santos, G; Herrera, F; Martín, V; Rodriguez, C; Rodriguez-Blanco, J, 2006)
"Melatonin secretion was nearly absent in the patients with pineal germinoma regardless of treatment option, even in the patient who had been untreated."1.30Twenty-four hour rhythm of melatonin in patients with a history of pineal and/or hypothalamo-neurohypophyseal germinoma. ( Hashimoto, S; Honma, K; Ikeda, J; Murata, J; Sawamura, Y, 1998)
"Melatonin values were higher in patients aged under 10 years than over 20 years in the absence of meningitis or tumor in the pineal region."1.28[The studies of melatonin values in the cerebrospinal fluid of hydrocephalic patients]. ( Eghwrudjakpor, PO; Kurisaka, M; Miyake, H; Mori, K, 1991)
"Melatonin serum levels were measured by radioimmunoassay on venous blood samples collected at 9:00 a."1.28A radiologic study by CT scan of pineal size in cancer patients: correlation to melatonin blood levels. ( Barni, S; Crispino, S; Ferri, L; Lissoni, P; Macchi, I; Salvini, E; Tagliabue, M; Tancini, G, 1989)
"Rarely, hydrocephalus may trigger true precocious puberty, a syndrome easily differentiated from pseudoprecocious puberty by endocrinologic tests."1.27Neuroendocrine aspects of pineal tumors. ( Fetell, MR; Stein, BM, 1986)

Research

Studies (71)

TimeframeStudies, this research(%)All Research%
pre-199022 (30.99)18.7374
1990's12 (16.90)18.2507
2000's9 (12.68)29.6817
2010's16 (22.54)24.3611
2020's12 (16.90)2.80

Authors

AuthorsStudies
Tanriover, G1
Dilmac, S1
Aytac, G1
Farooqi, AA1
Sindel, M1
Di Bella, G1
Borghetto, V1
Costanzo, E1
Ghareghani, M1
Zibara, K1
Reiter, RJ1
Rivest, S1
Datta, A1
Das, KK1
G, KK1
Jaiswal, AK1
Kumar, R1
Gagliardi, F1
De Domenico, P1
Garbin, E1
Snider, S1
Mortini, P1
Neamati, F1
Asemi, Z1
Zhou, N1
Wei, ZX1
Qi, ZX1
Gonzalez, A1
Nese, M1
Riboli, G1
Brighetti, G1
Sassi, V1
Camela, E1
Caselli, G1
Sassaroli, S1
Borlimi, R1
Aucoin, M1
Cooley, K1
Saunders, PR1
Carè, J1
Anheyer, D1
Medina, DN1
Cardozo, V1
Remy, D1
Hannan, N1
Garber, A1
Velayos, M1
Muñoz-Serrano, AJ1
Estefanía-Fernández, K1
Sarmiento Caldas, MC1
Moratilla Lapeña, L1
López-Santamaría, M1
López-Gutiérrez, JC1
Li, J1
Zhang, J1
Shen, S1
Zhang, B2
Yu, WW1
Toyoda, H1
Huang, DQ1
Le, MH1
Nguyen, MH1
Huang, R1
Zhu, L1
Wang, J8
Xue, L1
Liu, L2
Yan, X2
Huang, S1
Li, Y6
Xu, T1
Li, C2
Ji, F1
Ming, F1
Zhao, Y2
Cheng, J1
Wang, Y3
Zhao, H1
Hong, S1
Chen, K2
Zhao, XA1
Zou, L1
Sang, D1
Shao, H1
Guan, X1
Chen, X3
Chen, Y5
Wei, J1
Zhu, C1
Wu, C1
Moore, HB1
Barrett, CD1
Moore, EE1
Jhunjhunwala, R1
McIntyre, RC1
Moore, PK1
Hajizadeh, N1
Talmor, DS1
Sauaia, A1
Yaffe, MB1
Liu, C3
Lin, Y1
Dong, Y1
Wu, Y1
Bao, Y1
Yan, H2
Ma, J1
Fernández-Cuadros, ME1
Albaladejo-Florín, MJ1
Álava-Rabasa, S1
Usandizaga-Elio, I1
Martinez-Quintanilla Jimenez, D1
Peña-Lora, D1
Neira-Borrajo, I1
López-Muñoz, MJ1
Rodríguez-de-Cía, J1
Pérez-Moro, OS1
Abdallah, M1
Alsaleh, H1
Baradwan, A1
Alfawares, R1
Alobaid, A1
Rasheed, A1
Soliman, I1
Wendel Garcia, PD1
Fumeaux, T1
Guerci, P1
Heuberger, DM1
Montomoli, J2
Roche-Campo, F1
Schuepbach, RA1
Hilty, MP1
Poloni, TE1
Carlos, AF1
Cairati, M1
Cutaia, C1
Medici, V1
Marelli, E1
Ferrari, D1
Galli, A1
Bognetti, P1
Davin, A1
Cirrincione, A1
Ceretti, A1
Cereda, C1
Ceroni, M1
Tronconi, L1
Vitali, S1
Guaita, A1
Leeds, JS1
Raviprakash, V1
Jacques, T1
Scanlon, N1
Cundall, J1
Leeds, CM1
Riva, A1
Gray, EH1
Azarian, S1
Zamalloa, A1
McPhail, MJW1
Vincent, RP1
Williams, R1
Chokshi, S1
Patel, VC1
Edwards, LA1
Alqarawi, W1
Birnie, DH1
Golian, M1
Nair, GM1
Nery, PB1
Klein, A1
Davis, DR1
Sadek, MM1
Neilipovitz, D1
Johnson, CB1
Green, MS1
Redpath, C1
Miller, DC1
Beamer, P1
Billheimer, D1
Subbian, V1
Sorooshian, A1
Campbell, BS1
Mosier, JM1
Novaretti, JV1
Astur, DC1
Cavalcante, ELB1
Kaleka, CC1
Amaro, JT1
Cohen, M1
Huang, W1
Li, T1
Ling, Y1
Qian, ZP1
Zhang, YY1
Huang, D1
Xu, SB1
Liu, XH1
Xia, L1
Yang, Y3
Lu, SH1
Lu, HZ1
Zhang, R2
Ma, JX1
Tang, S1
Li, CM1
Wan, J1
Wang, JF1
Ma, JQ1
Luo, JJ1
Chen, HY2
Mi, SL1
Chen, SY1
Su, YG1
Ge, JB1
Milheiro, SA1
Gonçalves, J1
Lopes, RMRM1
Madureira, M1
Lobo, L1
Lopes, A1
Nogueira, F1
Fontinha, D1
Prudêncio, M1
M Piedade, MF1
Pinto, SN1
Florindo, PR1
Moreira, R1
Castillo-Lora, J1
Delley, MF1
Laga, SM1
Mayer, JM1
Sutjarit, N1
Thongon, N1
Weerachayaphorn, J1
Piyachaturawat, P1
Suksamrarn, A1
Suksen, K1
Papachristou, DJ1
Blair, HC1
Hu, Y1
Shen, P1
Zeng, N1
Wang, L4
Yan, D1
Cui, L1
Yang, K2
Zhai, C1
Yang, M1
Lao, X1
Sun, J1
Ma, N1
Wang, S1
Ye, W1
Guo, P1
Rahimi, S1
Singh, MP1
Gupta, J1
Nakanishi, I1
Ohkubo, K1
Shoji, Y1
Fujitaka, Y1
Shimoda, K1
Matsumoto, KI1
Fukuhara, K1
Hamada, H1
van der Boom, T1
Gruppen, EG1
Lefrandt, JD1
Connelly, MA1
Links, TP1
Dullaart, RPF1
Berry, JD1
Bedlack, R1
Mathews, D1
Agnese, W1
Apple, S1
Meloncelli, S1
Divizia, M1
Germani, G1
Adefegha, SA1
Bottari, NB1
Leal, DB1
de Andrade, CM1
Schetinger, MR1
Martínez-Velasco, A1
Perez-Ortiz, AC1
Antonio-Aguirre, B1
Martínez-Villaseñor, L1
Lira-Romero, E1
Palacio-Pastrana, C1
Zenteno, JC1
Ramirez, I1
Zepeda-Palacio, C1
Mendoza-Velásquez, C1
Camacho-Ordóñez, A1
Ortiz Bibriesca, DM1
Estrada-Mena, FJ1
Martin, BL1
Thompson, LC1
Kim, YH2
Snow, SJ1
Schladweiler, MC1
Phillips, P1
Harmon, M1
King, C1
Richards, J1
George, I1
Haykal-Coates, N1
Gilmour, MI1
Kodavanti, UP1
Hazari, MS1
Farraj, AK1
Shen, Z1
Zou, Y1
Gao, K1
Lazar, S1
Wurtzel, JGT1
Ma, P1
Goldfinger, LE1
Vukelic, M1
Laloo, A1
Kyttaris, VC1
Chen, R1
Chen, J2
Xun, J1
Hu, Z1
Huang, Q2
Steinhart, C1
Shen, Y1
Lu, H1
Mansuri, A1
Lokhande, K1
Kore, S1
Gaikwad, S1
Nawani, N1
Swamy, KV1
Junnarkar, M1
Pawar, S1
Shaheen, MY1
Basudan, AM1
Niazy, AA1
van den Beucken, JJJP1
Jansen, JA1
Alghamdi, HS1
Gao, Q2
Guo, X1
Cao, Y1
Jia, X1
Xu, S1
Lu, C2
Zhu, H2
Melku, M1
Abebe, G1
Teketel, A1
Asrie, F1
Yalew, A1
Biadgo, B1
Kassa, E1
Damtie, D1
Anlay, DZ1
Ahmed, MFE1
Ramadan, H1
Seinige, D1
Kehrenberg, C1
Abd El-Wahab, A1
Volkmann, N1
Kemper, N1
Schulz, J1
Hu, MY1
Wu, YN1
McEvoy, MP1
Wang, YF1
Cong, WL1
Liu, LP1
Li, XX1
Zhou, CL1
Chen, WM1
Wei, KL1
Tung, SY1
Shen, CH1
Chang, TS1
Yen, CW1
Hsieh, YY1
Chiu, WN1
Hu, JH1
Lu, SN1
Hung, CH1
Alakavuklar, MA1
Fuqua, C1
Luo, KL1
Underwood, RS1
Greenwald, I1
Elashiry, MM1
Elashiry, M1
Zeitoun, R1
Elsayed, R1
Tian, F1
Saber, SE1
Elashry, SH1
Tay, FR1
Cutler, CW1
O'Dowd, A1
Maciel, M1
Poole, ST1
Jobling, MG1
Rollenhagen, JE1
Woods, CM1
Sincock, SA1
McVeigh, AL1
Gregory, MJ1
Maves, RC1
Prouty, MG1
Holmes, RK1
Savarino, SJ1
Mor, MK1
Palevsky, PM1
Kaufman, JS1
Thiessen Philbrook, H1
Weisbord, SD1
Parikh, CR1
John, CM1
Phillips, NJ1
Jarvis, GA1
Zhu, Y1
Kilburn, S1
Kapoor, M1
Chaturvedi, S1
Shaw, KJ1
Chaturvedi, V1
Kong, X1
Zhang, T1
Xiao, H1
Feng, X1
Tu, H1
Feng, J1
Sabet, M1
Tarazi, Z1
Griffith, DC1
Nguyen, F1
Guan, P1
Guerrero, DT1
Kolla, V1
Naraparaju, K1
Perry, LM1
Soberman, D1
Pressly, BB1
Alferiev, IS1
Chorny, M1
Brodeur, GM1
Gao, X2
Cheng, YH1
Enten, GA1
DeSantis, AJ1
Gaponenko, V1
Majetschak, M1
Kim, DY1
Choi, MJ1
Ko, TK1
Lee, NH1
Kim, OH1
Cheon, HG1
Cai, H1
Yip, V1
Lee, MV1
Wong, S1
Saad, O1
Ma, S1
Ljumanovic, N1
Khojasteh, SC1
Kamath, AV1
Shen, BQ1
Cuypers, ML1
Chanteux, H1
Gillent, E1
Bonnaillie, P1
Saunders, K1
Beckers, C1
Delatour, C1
Dell'Aiera, S1
Ungell, AL1
Nicolaï, J1
Knapp, AK1
Chen, A2
Griffin-Nolan, RJ1
Baur, LE1
Carroll, CJW1
Gray, JE1
Hoffman, AM1
Li, X6
Post, AK1
Slette, IJ1
Collins, SL1
Luo, Y1
Smith, MD1
Temitayo, GI1
Olawande, B1
Emmanuel, YO1
Timothy, AT1
Kehinde, O1
Susan, LF1
Ezra, L1
Joseph, OO1
Lev, S1
Desmarini, D1
Liuwantara, D1
Sorrell, TC1
Hawthorne, WJ1
Djordjevic, JT1
Verso, MG1
Costantino, C1
Marrella, A1
Immordino, P1
Vitale, F1
Amodio, E1
Wang, YD1
Yao, WL1
Xin, ZM1
Han, TT1
Wang, ZG1
Chen, L1
Cai, C1
Zhang, Y4
Ba, D1
Wen, S1
Tian, Q1
Lv, W1
Cheng, G1
Li, N1
Yue, XY1
Chu, WJ1
Chen, Q1
Choi, ES1
Zhao, X3
Zhou, HD1
Sun, XF1
Sharma, S2
Chhoker, S1
Xie, C1
Ong, EWY1
Tan, ZK1
Evans, S1
Weinheimer, CJ1
Kovacs, A1
Williams, JW1
Randolph, GJ1
Jiang, W1
Barger, PM1
Mann, DL1
Liu, J2
Huang, Y1
Kong, L1
Yu, X1
Feng, B1
Liu, D1
Zhao, B1
Mendes, GC1
Yuan, P1
Ge, D1
Wang, WM1
Fontes, EPB1
Li, P1
Shan, L1
He, P1
Katoh, T1
Sengoku, T1
Hirata, K1
Ogata, K1
Suga, H1
Shun, C1
Yong-Yi, J1
Mei-Li, C1
Shi-Li, L1
Jian-Bo, Z1
Dan-Li, W1
Zhi-Min, G1
Ibrahim, AM1
Zakhary, SY1
Amin, SAW1
Ugurlu, M1
Fornari, VJ1
Hartmann, MSM1
Vanni, JR1
Rodriguez, R1
Langaro, MC1
Pelepenko, LE1
Zaia, AA1
Nakanjako, D1
Zalwango, F1
Wairagala, P1
Luboga, F1
Andia Biraro, I1
Bukirwa, VD1
Mboowa, MG1
Cose, S1
Seeley, J1
Elliott, A1
Zhao, G1
Sun, P1
Hao, S1
Wang, X1
Qu, G1
Xing, Y1
Xu, X1
Maierhofer, M1
Rieger, V1
Mayr, T1
Liu, Y3
Zhang, Q2
Bigliardi, AP1
Fernandes, CLF1
Pinto, EA1
Dos Santos, M1
Garcia, EM1
Baisch, PRM1
Soares, MCF1
Muccillo-Baisch, AL1
da Silva Júnior, FMR1
Yu, W1
Ju, C1
Wang, K1
Zheng, Z1
Liu, H1
Gao, Y1
Martínez-Navarro, EM1
Cebrián-Tarancón, C1
Moratalla-López, N1
Lorenzo, C1
Alonso, GL1
Salinas, RM1
Bermúdez de Castro, JM1
Modesto-Mata, M1
Martín-Francés, L1
García-Campos, C1
Martínez de Pinillos, M1
Martinón-Torres, M1
Hasani, M1
Wu, F2
Warriner, K1
Kurz, M1
Gretzke, D1
Hörlein, R1
Turpault, S1
Atzrodt, J1
Derdau, V1
Yao, Y1
Ou, X1
Zhao, S1
Tian, B1
Jin, S1
Jiang, Z1
Zhou, Z1
Liu, M2
Jiang, GD1
Mou, LH1
Chen, JJ1
Li, ZY1
He, SG1
Reale, E1
Fustinoni, S1
Mercadante, R1
Polledri, E1
Hopf, NB1
Grant, PC1
Levy, K1
Lattimer, TA1
Depner, RM1
Kerr, CW1
Sato, J1
Merenda, MEZ1
Uemoto, AT1
Dos Santos, MP1
Barion, MRL1
Carciofi, AC1
de Paula Dorigam, JC1
Ribeiro, LB1
Vasconcellos, RS1
Waller, SB1
Peter, CM1
Hoffmann, JF1
Cleff, MB1
Faria de, RO1
Zani, JL1
Martins, BA1
Sande, D1
Solares, MD1
Takahashi, JA1
Yang, S2
Jia, Y1
Yin, C1
Zhao, R1
Ojha, M1
Wu, B1
Deepa, M1
Mo, J1
Au, DW1
Wan, MT1
Shi, J1
Zhang, G1
Winkler, C1
Kong, RY1
Seemann, F1
Bianco, M1
Calvano, CD1
Ventura, G1
Bianco, G1
Losito, I1
Cataldi, TRI1
Angiolella, L1
Staudt, A1
Duarte, PF1
Amaral, BPD1
Peixoto Andrade, BCO1
Simas, NK1
Correa Ramos Leal, I1
Sangenito, LS1
Santos, ALSD1
de Oliveira, D1
Junges, A1
Cansian, RL1
Paroul, N1
Siu, J1
Klingler, L1
Hung, CT1
Jeong, SH1
Smith, S1
Tingle, MD1
Wagner Mackenzie, B1
Biswas, K1
Douglas, RG1
Oza, AM1
Lorusso, D1
Aghajanian, C1
Oaknin, A1
Dean, A1
Colombo, N1
Weberpals, JI1
Clamp, AR1
Scambia, G1
Leary, A1
Holloway, RW1
Gancedo, MA1
Fong, PC1
Goh, JC1
O'Malley, DM1
Armstrong, DK1
Banerjee, S1
García-Donas, J1
Swisher, EM1
Cella, D1
Meunier, J1
Goble, S1
Cameron, T1
Maloney, L1
Mörk, AC1
Bedel, J1
Ledermann, JA1
Coleman, RL1
Vlek, SL1
Burm, R1
Govers, TM1
Vleugels, MPH1
Tuynman, JB1
Mijatovic, V1
Leicht, AS1
Connor, J1
Conduit, N1
Vaquera, A1
Gómez, MA1
McKay, JA1
Church, AL1
Rubin, N1
Emory, TH1
Hoven, NF1
Kuehn-Hajder, JE1
Nelson, MT1
Ramanna, S1
Auerbach, EJ1
Moeller, S1
Bolan, PJ1
Fox, NP1
Leonard, M1
Sjerps, MJ1
Chang, EF1
Hyun, S1
Saejio, A1
Shanmugam, S1
Liu, X1
Sun, M1
Bai, Z1
Jaque-Fernandez, F1
Beaulant, A1
Berthier, C1
Monteiro, L1
Allard, B1
Casas, M1
Rieusset, J1
Jacquemond, V1
Góngora-García, OR1
Aca-Aca, G1
Baz-Rodríguez, SA1
Monte, A1
Maganaris, C1
Baltzopoulos, V1
Zamparo, P1
Wang, Z3
Hou, Y1
Cai, L1
Tu, YJ1
Tan, B1
Jiang, L1
Wu, ZH1
Yu, HJ1
Li, XQ1
Yang, AD1
Titze, IR1
Palaparthi, A1
Mau, T1
González, MA1
Goiri, F1
Barandika, JF1
García-Pérez, AL1
Jatt, LP1
Gandhi, MM1
Guo, R1
Sukhija-Cohen, A1
Bhattacharya, D2
Tseng, CH1
Chew, KW1
Onwumere, J1
Pia Tek, J1
Budnyak, T1
Budnyk, S1
Karim, Z1
Thersleff, T1
Kuśtrowski, P1
Mathew, AP1
Slabon, A1
Guo, M1
Zhao, T1
Xing, Z1
Qiu, Y1
Pan, K1
Li, Z2
Zhou, W1
Ghassemi Tabrizi, S1
Arbuznikov, AV1
Jiménez-Hoyos, CA1
Kaupp, M1
Lin, MH2
Bulman, DM1
Remucal, CK1
Chaplin, BP1
Laguerre, A1
George, LA1
Gall, ET1
Emerson, MS1
Wang, H4
Maginn, EJ1
Margulis, CJ1
Li, H2
Feng, W1
Kang, X2
Yan, S1
Chao, M1
Mo, S1
Sun, W1
Lu, Y1
Chen, C1
Stevens, DM1
Adiseshaiah, P1
Dasa, SSK1
Potter, TM1
Skoczen, SL1
Snapp, KS1
Cedrone, E1
Patel, N1
Busman-Sahay, K1
Rosen, EP1
Sykes, C1
Cottrell, M1
Dobrovolskaia, MA1
Estes, JD1
Kashuba, ADM1
Stern, ST1
Özütemiz, C1
Neil, EC1
Tanwar, M1
Rubin, NT1
Ozturk, K1
Cayci, Z1
Duscha, BD1
Kraus, WE1
Jones, WS1
Robbins, JL1
Piner, LW1
Huffman, KM1
Allen, JD1
Annex, BH1
Mehmood, T1
Ahmad, I1
Bibi, S1
Mustafa, B1
Ali, I1
Dahal, RH1
Chaudhary, DK1
Kim, DU1
Kim, J1
Yeter, HH1
Gonul, I1
Guz, G1
Helvaci, O1
Korucu, B1
Akcay, OF1
Derici, U1
Arinsoy, T1
Neffati, R1
Judeinstein, P1
Rault, J1
Xu, Y1
Chai, X1
Ren, T1
Yu, S1
Fu, Q2
Ye, J1
Ge, X1
Song, J1
Yang, H3
El-Baba, TJ1
Lutomski, CA1
Kantsadi, AL1
Malla, TR1
John, T1
Mikhailov, V1
Bolla, JR1
Schofield, CJ1
Zitzmann, N1
Vakonakis, I1
Robinson, CV1
Langham, MC1
Caporale, AS1
Wehrli, FW1
Parry, S1
Schwartz, N1
den Boer, RB1
Jones, KI1
Ash, S1
van Boxel, GI1
Gillies, RS1
O'Donnell, T1
Ruurda, JP1
Sgromo, B1
Silva, MA1
Maynard, ND1
Sivieri, EM1
Eichenwald, EC1
Rub, D1
Abbasi, S1
Krahnert, I1
Bolze, A1
Gibon, Y1
Fernie, AR1
Huang, L1
Wan, Y1
Dang, Z1
Yang, P1
Yang, Q1
Wu, S2
Lin, CC1
Hsu, CT1
Liu, W2
Huang, SC1
Kortz, U1
Mougharbel, AS1
Chen, TY1
Hu, CW1
Lee, JF1
Wang, CC1
Liao, YF1
Li, LJ1
Li, L1
Peng, S1
Stimming, U1
Hebbar Kannur, K1
Yaqub, TB1
Pupier, C1
Héau, C1
Cavaleiro, A1
Yamamoto, S1
Ono, A1
Matsui, J1
Hoshino, N1
Akutagawa, T1
Miyashita, T1
Mitsuishi, M1
Patel, SM1
Smith, TG1
Morton, M1
Stiers, KM1
Seravalli, J1
Mayclin, SJ1
Edwards, TE1
Tanner, JJ1
Becker, DF1
Butcher, TW1
Yang, JL1
Hartwig, JF1
Yu, MF1
Xia, ZZ1
Yao, JC1
Feng, Z2
Li, DH1
Liu, T1
Cheng, GJ1
He, DL1
Li, XH1
Huurman, R1
Schinkel, AFL1
de Jong, PL1
van Slegtenhorst, MA1
Hirsch, A1
Michels, M1
Kataja, A1
Tarvasmäki, T1
Lassus, J1
Sionis, A1
Mebazaa, A1
Pulkki, K1
Banaszewski, M1
Carubelli, V1
Hongisto, M1
Jankowska, E1
Jurkko, R1
Jäntti, T1
Kasztura, M1
Parissis, J1
Sabell, T1
Silva-Cardoso, J1
Spinar, J1
Tolppanen, H1
Harjola, VP1
Carsetti, A1
Damiani, E1
Casarotta, E1
Scorcella, C1
Domizi, R1
Gasparri, F1
Gabbanelli, V1
Pantanetti, S1
Carozza, R1
Adrario, E1
Donati, A1
Almada, E1
Pariani, A1
Rivabella Maknis, T1
Hidalgo, F1
Vena, R1
Favre, C1
Larocca, MC1
Lu, ZY1
Jiang, WD1
Wu, P1
Kuang, SY1
Tang, L1
Yang, J1
Zhou, XQ1
Feng, L1
Leal, M1
Zampini, IC1
Mercado, MI1
Moreno, MA1
Simirgiotis, MJ1
Bórquez, J1
Ponessa, G1
Isla, MI1
Saliu, IO1
Amoo, ZA1
Khan, MF1
Olaleye, MT1
Rema, V1
Akinmoladun, AC1
Khan, AU1
Rahman, AU1
Yuan, Q1
Ahmad, A1
Khan, ZUH1
Mahnashi, MH1
Alyami, BA1
Alqahtani, YS1
Ullah, S1
Wirman, AP1
Gao, M1
Deng, L1
Zhang, K1
Wang, M1
Xia, Z1
Gao, D1
Balkissou, AD1
Poka-Mayap, V1
Massongo, M1
Djenabou, A1
Endale-Mangamba, LM1
Olomo, EJ1
Boulleys-Nana, JR1
Diffo-Sonkoue, L1
Adidigue-Ndiome, R1
Alexandra, AJE1
Haman-Wabi, AB1
Adama, S1
Iddi-Faical, A1
Pefura-Yone, EW1
Zhao, Q1
Tong, W1
Ge, C1
Zhao, D1
Norbäck, D1
Li, B1
Zhao, Z2
Huang, C1
Zhang, X1
Qian, H1
Yang, X1
Sun, Y1
Sundell, J1
Deng, Q1
Kim, HJ1
Jeon, JW1
Hwang, SM1
Chu, KI1
Cha, YH1
Kwak, YD1
Choi, SD1
Aslam, M1
Kim, CG1
Zhou, J1
Yang, E1
Yang, W1
Panciroli, C1
Esteve, A1
Muñoz-Ferrer, A1
Abad, J1
Hernandez, JM1
Balaña, C1
Lucente, G1
Comas, S1
Villà, S1
Wang, C1
Qi, Q1
Kong, Y1
Li, W1
Huang, B1
Doğanlar, O1
Doğanlar, ZB1
Delen, E1
Doğan, A1
Pickering, L1
Main, KM1
Feldt-Rasmussen, U1
Klose, M1
Sehested, A1
Mathiasen, R1
Jennum, P1
Gu, J1
Lu, Z1
Ji, C1
Lei, Z1
Zhang, HT1
Ma, H1
Hu, L1
Zhang, S1
Zhao, C1
Fang, Z1
Wu, L2
Lee, H1
Lee, HJ1
Jung, JH2
Shin, EA1
Kim, SH2
Rosenkranz, E1
Thissen, A1
Siegel, S1
Piroth, M1
Clusmann, H1
Gebauer, J1
Brabant, G1
Kreitschmann-Andermahr, I1
Maitra, S1
Das, S1
Bhattacharya, S1
Sung, GJ1
Kwak, S1
Park, SH1
Song, JH1
Kim, H1
Choi, KC1
Lai, SW1
Liu, YS1
Lu, DY1
Tsai, CF1
Martín, V3
Sanchez-Sanchez, AM2
Herrera, F2
Gomez-Manzano, C1
Fueyo, J1
Alvarez-Vega, MA2
Antolín, I3
Rodriguez, C3
Liu, YJ1
Meng, FT1
Zhou, JN1
Puente-Moncada, N1
Gomez-Lobo, M1
Jumnongprakhon, P1
Govitrapong, P1
Tocharus, C1
Pinkaew, D1
Tocharus, J1
Kinker, GS1
Oba-Shinjo, SM1
Carvalho-Sousa, CE1
Muxel, SM1
Marie, SK1
Markus, RP1
Fernandes, PA1
Tuntapakul, S1
Kitkhuandee, A1
Kanpittaya, J1
Johns, J1
Johns, NP1
Májovský, M1
Řezáčová, L1
Sumová, A1
Pospíšilová, L1
Netuka, D1
Bradáč, O1
Beneš, V1
R T Ramirez, R1
Poling, MI1
deCourten, JF1
Chamberlain, RL1
Leston, J1
Mottolese, C2
Champier, J2
Jouvet, A2
Brun, J1
Sindou, M1
Chazot, G1
Claustrat, B3
Fèvre-Montange, M2
Mandera, M1
Wion-Barbot, N2
Berger, F2
Wion, D2
Carrera-Gonzalez, P1
García-Santos, G1
Rodriguez-Blanco, J1
Berk, L1
Berkey, B1
Rich, T1
Hrushesky, W1
Blask, D1
Gallagher, M1
Kudrimoti, M1
McGarry, RC1
Suh, J1
Mehta, M1
Szathmari, A1
Brisson, C1
Reboul, A1
Fauchon, F1
Mori, K2
Tharandt, L1
Reinwein, D1
Cardinali, DP1
Vacas, MI1
Preslock, JP1
Kraft, K1
Edelmann, A1
Entzian, W1
Nocke-Finck, L1
Dempsey, RJ1
Chandler, WF1
Neuwelt, EA2
Lewy, AJ2
Lissoni, P3
Barni, S2
Ardizzoia, A1
Tancini, G2
Conti, A1
Maestroni, G1
Etzioni, A1
Luboshitzky, R1
Tiosano, D1
Ben-Harush, M1
Goldsher, D1
Lavie, P1
García-Patterson, A1
Puig-Domingo, M1
Webb, SM1
Grimoldi, N1
Tomei, G1
Stankov, B1
Lucini, V1
Masini, B1
Caputo, V1
Repetti, ML1
Lazzarini, G1
Gaini, SM1
Lucarini, C1
Fraschini, F1
Villani, R1
Murata, J1
Sawamura, Y1
Ikeda, J1
Hashimoto, S1
Honma, K1
Giani, L1
Zerbini, S1
Trabattoni, P1
Rovelli, F1
Jan, JE1
Tai, J1
Hahn, G1
Rothstein, RR1
Gurney, JG1
van Wijngaarden, E1
Barber, SG3
Smith, JA2
Cove, DH1
Smith, SC1
London, DR1
Shaw, KM1
Kennaway, DJ1
McCulloch, G1
Matthews, CD1
Seamark, RF1
Makarov, AIu2
Kiselev, VN1
Loboda, EB2
Hughes, RC1
Kappers, JA1
Pomnikov, VG1
Sheludchenko, FI1
Goncharova, VA1
Hayashi, T1
Anegawa, S1
Torigoe, R1
Kurisaka, M1
Miyake, H1
Eghwrudjakpor, PO1
Ohashi, M1
Nawata, H1
Yamada, N1
Iwasa, H1
Kurokawa, N1
Fujimoto, K1
Kawashima, K1
Masuzawa, T1
Tagliabue, M1
Macchi, I1
Crispino, S1
Ferri, L1
Salvini, E1
Erlich, SS1
Apuzzo, ML1
Fetell, MR1
Stein, BM1
Miles, A2
Philbrick, D2
Vorkapic, P1
Waldhauser, F1
Bruckner, R1
Biegelmayer, C1
Schmidbauer, M1
Pendl, G1
Mickey, B1
Tidmarsh, SF1
Shaw, DM1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomized Phase II Study of A.M. and P.M. Melatonin for Brain Metastasis in RPA Class II Patients[NCT00031967]Phase 20 participants Interventional2002-05-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

16 reviews available for melatonin and Brain Neoplasms

ArticleYear
Reduced melatonin levels may facilitate glioblastoma initiation in the subventricular zone.
    Expert reviews in molecular medicine, 2022, 05-16, Volume: 24

    Topics: Adult; Brain Neoplasms; Female; Glioblastoma; Humans; Lateral Ventricles; Male; Melatonin; Neural St

2022
Primary Gamma Knife Radiosurgery for pineal region tumors: A systematic review and pooled analysis of available literature with histological stratification.
    Journal of pineal research, 2023, Volume: 75, Issue:4

    Topics: Brain Neoplasms; Glioma; Humans; Melatonin; Neoplasms, Germ Cell and Embryonal; Pineal Gland; Pineal

2023
The effects of melatonin on signaling pathways and molecules involved in glioma.
    Fundamental & clinical pharmacology, 2020, Volume: 34, Issue:2

    Topics: Animals; Apoptosis; Brain Neoplasms; Cell Differentiation; Cell Proliferation; Disease Progression;

2020
Antioxidants and Neuron-Astrocyte Interplay in Brain Physiology: Melatonin, a Neighbor to Rely on.
    Neurochemical research, 2021, Volume: 46, Issue:1

    Topics: Alzheimer Disease; Animals; Antioxidants; Astrocytes; Brain; Brain Neoplasms; Cell Line, Tumor; Huma

2021
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
Melatonin and its anti-glioma functions: a comprehensive review.
    Reviews in the neurosciences, 2019, 07-26, Volume: 30, Issue:5

    Topics: Animals; Antineoplastic Agents; Antioxidants; Brain Neoplasms; Glioma; Humans; Melatonin; Signal Tra

2019
[Usefulness of melatonin in the diagnostics and therapy of pineal gland and brain neoplasms].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2003, Volume: 56, Issue:11-12

    Topics: Brain Neoplasms; Circadian Rhythm; Humans; Melatonin; Pineal Gland; Pinealoma

2003
[Disruptions of circadian rhythm in neurologic disorders].
    L'Encephale, 2006, Volume: 32, Issue:5 Pt 2

    Topics: Autonomic Nervous System Diseases; Body Temperature Regulation; Brain Neoplasms; Central Nervous Sys

2006
[Melatonin, a clinically important hormone?].
    Deutsche medizinische Wochenschrift (1946), 1983, Mar-25, Volume: 108, Issue:12

    Topics: Animals; Brain Neoplasms; Breast Neoplasms; Central Nervous System; Circadian Rhythm; Female; Humans

1983
Pineal gland, photoperiodic responses, and puberty.
    Journal of endocrinological investigation, 1984, Volume: 7, Issue:2

    Topics: Animals; Brain Neoplasms; Circadian Rhythm; Female; Humans; Light; Luteinizing Hormone; Male; Melato

1984
The pineal gland: basic implications and clinical correlations.
    Endocrine reviews, 1984,Spring, Volume: 5, Issue:2

    Topics: Adrenal Glands; Animals; Arginine Vasopressin; Brain Neoplasms; Cricetinae; Female; Gonads; Humans;

1984
Thirty years of human pineal research: do we know its clinical relevance?
    Journal of pineal research, 1996, Volume: 20, Issue:1

    Topics: Adult; Aging; Animals; Brain Neoplasms; Child; Circadian Rhythm; Endocrine System Diseases; Humans;

1996
Extremely low frequency electromagnetic fields (EMF) and brain cancer in adults and children: review and comment.
    Neuro-oncology, 1999, Volume: 1, Issue:3

    Topics: Adult; Brain Neoplasms; Calcium; Cell Transformation, Neoplastic; Child; Cluster Analysis; Cocarcino

1999
The pineal gland: a review of the biochemistry, physiology and pharmacological potential of melatonin and other pineal substances.
    Advances in drug research, 1977, Volume: 11

    Topics: Animals; Brain; Brain Diseases; Brain Neoplasms; Calcinosis; Circadian Rhythm; Endocrine Glands; Epi

1977
The pineal gland: anatomy, physiology, and clinical significance.
    Journal of neurosurgery, 1985, Volume: 63, Issue:3

    Topics: Analgesia; Animals; Brain Neoplasms; Circadian Rhythm; Depression; Electroencephalography; Humans; H

1985
Melatonin: perspectives in laboratory medicine and clinical research.
    Critical reviews in clinical laboratory sciences, 1987, Volume: 25, Issue:3

    Topics: Brain Neoplasms; Breast Neoplasms; Humans; Male; Melanoma; Melatonin; Mood Disorders; Prostatic Neop

1987

Trials

4 trials available for melatonin and Brain Neoplasms

ArticleYear
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119).
    International journal of radiation oncology, biology, physics, 2007, Jul-01, Volume: 68, Issue:3

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Female; Humans; Melatonin; Middle A

2007
A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms.
    Cancer, 1994, Feb-01, Volume: 73, Issue:3

    Topics: Adult; Aged; Brain Neoplasms; Drug Evaluation; Female; Humans; Male; Melatonin; Middle Aged; Quality

1994
Biotherapy with the pineal immunomodulating hormone melatonin versus melatonin plus aloe vera in untreatable advanced solid neoplasms.
    Natural immunity, 1998, Volume: 16, Issue:1

    Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aloe; Brain Neoplasms; Breast Neoplasms; Drug Thera

1998

Other Studies

52 other studies available for melatonin and Brain Neoplasms

ArticleYear
Effects of Melatonin and Doxorubicin on Primary Tumor And Metastasis in Breast Cancer Model.
    Anti-cancer agents in medicinal chemistry, 2022, Volume: 22, Issue:10

    Topics: Animals; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Female; Humans; Melatonin

2022
A retrospective observational study on cases of anaplastic brain tumors treated with the Di Bella Method: A rationale and effectiveness.
    Neuro endocrinology letters, 2021, Nov-30, Volume: 42, Issue:7

    Topics: Acetazolamide; Antioxidants; Brain Neoplasms; Ditiocarb; Glioblastoma; Humans; Hydroxyurea; Melatoni

2021
Temporal profile of serum melatonin levels in paediatric pineal tumours subjected to surgery: newer insights.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2023, Volume: 39, Issue:9

    Topics: Brain Neoplasms; Child; Circadian Rhythm; Humans; Melatonin; Pineal Gland; Pinealoma; Supratentorial

2023
Inhibition of autophagy triggers melatonin-induced apoptosis in glioblastoma cells.
    BMC neuroscience, 2019, 12-23, Volume: 20, Issue:1

    Topics: Acetamides; Antineoplastic Agents; Apoptosis; Autophagy; Brain Neoplasms; Cell Line, Tumor; Dose-Res

2019
Prospective pilot study to explore the melatonin level in brain tumor patients undergoing radiotherapy.
    Sleep & breathing = Schlaf & Atmung, 2022, Volume: 26, Issue:1

    Topics: Adult; Brain Neoplasms; Female; Follow-Up Studies; Humans; Male; Melatonin; Middle Aged; Pilot Proje

2022
miR-6858 plays a key role in the process of melatonin inhibition of the malignant biological behavior of glioma.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2021, Volume: 87

    Topics: Animals; Antioxidants; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Re

2021
The role of melatonin in angio-miR-associated inhibition of tumorigenesis and invasion in human glioblastoma tumour spheroids.
    Tissue & cell, 2021, Volume: 73

    Topics: Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neopla

2021
Brain tumours in children and adolescents may affect the circadian rhythm and quality of life.
    Acta paediatrica (Oslo, Norway : 1992), 2021, Volume: 110, Issue:12

    Topics: Adolescent; Brain Neoplasms; Child; Circadian Rhythm; Female; Humans; Male; Melatonin; Quality of Li

2021
Melatonin inhibits proliferation and invasion via repression of miRNA-155 in glioma cells.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 93

    Topics: Antioxidants; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioma; Humans; Melatonin; Micr

2017
The melatonin-MT1 receptor axis modulates tumor growth in PTEN-mutated gliomas.
    Biochemical and biophysical research communications, 2018, 02-19, Volume: 496, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Cell Proliferation; Female; Glioma; Humans; Mal

2018
Melatonin disturbs SUMOylation-mediated crosstalk between c-Myc and nestin via MT1 activation and promotes the sensitivity of paclitaxel in brain cancer stem cells.
    Journal of pineal research, 2018, Volume: 65, Issue:2

    Topics: A549 Cells; Brain Neoplasms; HEK293 Cells; Hep G2 Cells; Humans; Matrix Metalloproteinase 14; Melato

2018
Melatonin secretion following brain midline irradiation is diminished, but not correlated with subjective sleep disturbances.
    Clinical endocrinology, 2018, Volume: 89, Issue:6

    Topics: Adolescent; Adult; Aged; Brain; Brain Neoplasms; Cross-Sectional Studies; Female; Humans; Leukemia;

2018
Inhibition of TFEB oligomerization by co-treatment of melatonin with vorinostat promotes the therapeutic sensitivity in glioblastoma and glioma stem cells.
    Journal of pineal research, 2019, Volume: 66, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Basic Helix-Loop-Helix Leucine Z

2019
Melatonin Modulates the Microenvironment of Glioblastoma Multiforme by Targeting Sirtuin 1.
    Nutrients, 2019, Jun-14, Volume: 11, Issue:6

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Melatonin; Mice; Monocytes; Signal

2019
Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells.
    British journal of cancer, 2013, May-28, Volume: 108, Issue:10

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette

2013
Serotoninergic and melatoninergic systems are expressed in mouse embryonic fibroblasts NIH3T3 cells.
    Neuro endocrinology letters, 2013, Volume: 34, Issue:3

    Topics: Animals; Apolipoproteins E; Astrocytes; Brain Neoplasms; Cell Line, Tumor; Fibroblasts; Gene Express

2013
Involvement of autophagy in melatonin-induced cytotoxicity in glioma-initiating cells.
    Journal of pineal research, 2014, Volume: 57, Issue:3

    Topics: Autophagy; Base Sequence; Brain Neoplasms; Flow Cytometry; Glioma; Humans; Melatonin; Microscopy, El

2014
Melatonin Protects Methamphetamine-Induced Neuroinflammation Through NF-κB and Nrf2 Pathways in Glioma Cell Line.
    Neurochemical research, 2015, Volume: 40, Issue:7

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Down-Regulation; Glioma; Melatonin; Methamphetamine; NF-

2015
Melatonergic system-based two-gene index is prognostic in human gliomas.
    Journal of pineal research, 2016, Volume: 60, Issue:1

    Topics: Acetylserotonin O-Methyltransferase; Animals; Brain Neoplasms; Cell Line, Tumor; Cytochrome P-450 CY

2016
Pineal calcification is associated with pediatric primary brain tumor.
    Asia-Pacific journal of clinical oncology, 2016, Volume: 12, Issue:4

    Topics: Adolescent; Brain Neoplasms; Calcinosis; Child; Child, Preschool; Female; Glioblastoma; Humans; Male

2016
Melatonin and cortisol secretion profile in patients with pineal cyst before and after pineal cyst resection.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2017, Volume: 39

    Topics: Adult; Animals; Biomarkers; Brain Neoplasms; Circadian Rhythm; Cysts; Female; Headache; Humans; Hydr

2017
Potential positive feedback loop of pineal cyst and posttraumatic stress disorder.
    Medical hypotheses, 2017, Volume: 100

    Topics: Adult; Brain Neoplasms; Cysts; Female; Homeostasis; Humans; Incidental Findings; Magnetic Resonance

2017
Contribution of the daily melatonin profile to diagnosis of tumors of the pineal region.
    Journal of neuro-oncology, 2009, Volume: 93, Issue:3

    Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Brain Neoplasms; Child; Circadian Rhythm; Female; Humans

2009
Should we control the pineal status of patients following brain radiotherapy?
    Journal of neuro-oncology, 2005, Volume: 74, Issue:3

    Topics: Brain Neoplasms; Cranial Irradiation; Humans; Melatonin; Pineal Gland

2005
Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin.
    Cancer research, 2006, Jan-15, Volume: 66, Issue:2

    Topics: Animals; Antioxidants; Brain Neoplasms; Cell Cycle; Cell Proliferation; Free Radicals; Glioma; Melat

2006
Glioma, melatonin, and radiotherapy.
    Cancer research, 2006, Jun-15, Volume: 66, Issue:12

    Topics: Animals; Brain Neoplasms; Glioma; Melatonin; Pineal Gland; Rats

2006
Histological features and expression of enzymes implicated in melatonin synthesis in pineal parenchymal tumours and in cultured tumoural pineal cells.
    Neuropathology and applied neurobiology, 2008, Volume: 34, Issue:3

    Topics: Acetylserotonin O-Methyltransferase; Adult; Aged; Arylalkylamine N-Acetyltransferase; Brain Neoplasm

2008
[Endocrinopathy associated with pineal tumors (2)].
    Neurologia medico-chirurgica, 1981, Volume: 21, Issue:5

    Topics: Brain Neoplasms; Chorionic Gonadotropin; Endocrine System Diseases; Gonadotropin-Releasing Hormone;

1981
Suppression of plasma prolactin in a patient with a pinealocytoma.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1984, Volume: 16, Issue:6

    Topics: Adolescent; Brain Neoplasms; Circadian Rhythm; Growth Hormone; Humans; Hydrocortisone; Hypothalamo-H

1984
Abnormal serum melatonin levels in patients with intrasellar tumors.
    Neurosurgery, 1984, Volume: 15, Issue:6

    Topics: Adenoma; Adult; Aged; Brain Neoplasms; Craniopharyngioma; Cushing Syndrome; Female; Humans; Male; Me

1984
Disappearance of plasma melatonin after removal of a neoplastic pineal gland.
    The New England journal of medicine, 1983, May-12, Volume: 308, Issue:19

    Topics: Adolescent; Astrocytoma; Brain Neoplasms; Circadian Rhythm; Gas Chromatography-Mass Spectrometry; Hu

1983
Melatonin replacement corrects sleep disturbances in a child with pineal tumor.
    Neurology, 1996, Volume: 46, Issue:1

    Topics: Adolescent; Brain Neoplasms; Humans; Male; Melatonin; Pineal Gland; Sleep; Sleep Initiation and Main

1996
Neuroendocrine, immunohistochemical, and ultrastructural study of pineal region tumors.
    Journal of pineal research, 1998, Volume: 25, Issue:3

    Topics: Adult; alpha-Fetoproteins; Biomarkers, Tumor; Brain Neoplasms; Carcinoembryonic Antigen; Child; Chor

1998
Twenty-four hour rhythm of melatonin in patients with a history of pineal and/or hypothalamo-neurohypophyseal germinoma.
    Journal of pineal research, 1998, Volume: 25, Issue:3

    Topics: Adolescent; Adult; Brain Neoplasms; Child; Circadian Rhythm; Germinoma; Humans; Hypothalamic Neoplas

1998
Melatonin replacement therapy in a child with a pineal tumor.
    Journal of child neurology, 2001, Volume: 16, Issue:2

    Topics: Adolescent; Brain Neoplasms; Child; Chronic Disease; Dose-Response Relationship, Drug; Female; Hormo

2001
Marker for pineal tumours?
    Lancet (London, England), 1978, Aug-12, Volume: 2, Issue:8085

    Topics: Adolescent; Adult; Aged; Brain Neoplasms; Chorionic Gonadotropin; Female; Humans; Male; Melatonin; P

1978
Plasma melatonin, luteinizing hormone, follicle-stimulating hormone, prolactin, and corticoids in two patients with pinealoma.
    The Journal of clinical endocrinology and metabolism, 1979, Volume: 49, Issue:1

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Brain Neoplasms; Follicle Stimulating Hormone; Gonadotro

1979
Melatonin as a marker for pineal tumours.
    British medical journal, 1978, Sep-23, Volume: 2, Issue:6141

    Topics: Brain Neoplasms; Circadian Rhythm; Humans; Melatonin; Pineal Gland

1978
[Cerebrospinal fluid melatonin in diseases of the nervous system].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1977, Volume: 77, Issue:12

    Topics: Adolescent; Adult; Arachnoiditis; Brain Diseases; Brain Injuries; Brain Neoplasms; Epilepsy; Female;

1977
Melatonin as a tumour marker in a patient with pineal tumour.
    British medical journal, 1978, Jul-29, Volume: 2, Issue:6133

    Topics: Adult; Brain Neoplasms; Humans; Male; Melatonin; Methods; Pinealoma

1978
Melatonin as a tumour marker in a patient with pineal tumour.
    British medical journal, 1978, Aug-26, Volume: 2, Issue:6137

    Topics: Adolescent; Adult; Brain Neoplasms; Humans; Male; Melatonin; Pineal Gland; Pinealoma; Radioimmunoass

1978
The mammalian pineal gland, a survey.
    Acta neurochirurgica, 1976, Volume: 34, Issue:1-4

    Topics: Animals; Brain Neoplasms; Circadian Rhythm; History, 19th Century; Humans; Light; Melatonin; Netherl

1976
[Serotonin and kinins in the cerebrospinal fluid in brain tumors].
    Voprosy onkologii, 1991, Volume: 37, Issue:4

    Topics: Adult; Aged; Brain Neoplasms; Female; Fluorometry; Humans; Hydroxyindoleacetic Acid; Kinins; Male; M

1991
[Effects of hypothermal and circulatory arrest on the auditory brainstem response during operation in children].
    No to shinkei = Brain and nerve, 1991, Volume: 43, Issue:7

    Topics: Adolescent; Adult; Aged; Aging; Brain Neoplasms; Child; Child, Preschool; Chromatography, High Press

1991
[The studies of melatonin values in the cerebrospinal fluid of hydrocephalic patients].
    No to shinkei = Brain and nerve, 1991, Volume: 43, Issue:7

    Topics: Adolescent; Adult; Aged; Aging; Brain Neoplasms; Child; Child, Preschool; Chromatography, High Press

1991
[Plasma and salivary melatonin assay and the clinical significance].
    Nihon rinsho. Japanese journal of clinical medicine, 1990, Volume: 48 Suppl

    Topics: Biomarkers, Tumor; Brain Neoplasms; Circadian Rhythm; Depressive Disorder; Gas Chromatography-Mass S

1990
[Melatonin secretion in intracranial tumor].
    No to shinkei = Brain and nerve, 1990, Volume: 42, Issue:2

    Topics: Adolescent; Adult; Brain Neoplasms; Circadian Rhythm; Female; Humans; Male; Melatonin; Radioimmunoas

1990
A radiologic study by CT scan of pineal size in cancer patients: correlation to melatonin blood levels.
    Tumori, 1989, Jun-30, Volume: 75, Issue:3

    Topics: Adult; Aged; Brain Neoplasms; Female; Humans; Male; Melatonin; Middle Aged; Pineal Gland; Tomography

1989
Neuroendocrine aspects of pineal tumors.
    Neurologic clinics, 1986, Volume: 4, Issue:4

    Topics: Brain Neoplasms; Cysts; Diabetes Insipidus; Humans; Hydrocephalus; Melatonin; Neoplasms, Germ Cell a

1986
Serum melatonin levels: a new neurodiagnostic tool in pineal region tumors?
    Neurosurgery, 1987, Volume: 21, Issue:6

    Topics: Adolescent; Adult; Brain Neoplasms; Circadian Rhythm; Female; Humans; Infant; Male; Melatonin; Middl

1987
The importance of melatonin and tumor markers in pineal tumors.
    Journal of neural transmission. Supplementum, 1986, Volume: 21

    Topics: Adolescent; Brain Neoplasms; Circadian Rhythm; Humans; Male; Melatonin; Middle Aged; Pineal Gland

1986
Diagnostic potential of melatonin analysis in pineal tumors.
    The New England journal of medicine, 1985, Aug-01, Volume: 313, Issue:5

    Topics: Adolescent; Brain Neoplasms; Female; Humans; Melatonin; Pineal Gland; Pinealoma

1985